HCA(US:HCA) Benzingaยท2025-10-24 14:23Core Insights - HCA Healthcare Inc. reported strong third-quarter 2025 financial results, exceeding analyst expectations in both revenue and earnings [1][2]. Financial Performance - Total revenues reached $19.16 billion, marking a 9.6% year-over-year increase and surpassing the consensus estimate of $18.57 billion [2]. - Adjusted earnings were reported at $6.96, up from $4.90 a year ago, exceeding the consensus of $5.72 [2]. - Adjusted EBITDA totaled $3.87 billion, compared to $3.267 billion in the same quarter last year [4]. - Cash flows from operating activities amounted to $4.42 billion, an increase from $3.515 billion in Q3 2024 [4]. Operational Metrics - Same-facility admissions increased by 2.1%, while same-facility equivalent admissions rose by 2.4% [3]. - Emergency room visits at same facilities grew by 1.3%, inpatient surgeries increased by 1.4%, and outpatient surgeries rose by 1.1% [3]. - Same-facility revenue per equivalent admission grew by 6.6% [3]. Guidance and Outlook - HCA Healthcare raised its fiscal year 2025 guidance for adjusted earnings from $25.50 to $27 to a new range of $27 to $28, exceeding the consensus of $26.33 [5]. - The sales guidance for 2025 was revised from $74 billion to $76 billion to a new range of $75 billion to $76.5 billion, compared to the consensus of $75.02 billion [5]. - The forecast for 2025 net income was updated to a range of $6.495 billion to $6.715 billion, up from the previous guidance of $6.11 billion to $6.48 billion [5]. - Adjusted EBITDA guidance was raised from a range of $14.70 billion to $15.30 billion to a new range of $15.25 billion to $15.65 billion [6]. Stock Performance - HCA Healthcare shares increased by 3.83% to $457.00, reaching a new 52-week high [6].